sales_goretiGoreti Sales
BioMark, Sensor Research / ISEP, Porto

Goreti Sales received a 6-year degree in Pharmaceutical Sciences, in 1994, from the Faculty of Pharmacy of Porto University. She received a Ph.D. in Analytical Chemistry, in 2000, from the same university. From 1999 to 2005 she was an Assistant Professor in the School of Engineering of the Polytechnique School of Porto, in the Chemical Engineering Department. Since 2006, she is Adjunct Professor in the same school and has developed in parallel relevant scientific activities in the field of nanotechnology, biosensing and materials. She has an h-index of 18 (Scopus, author ID 7005174717), for a total of 105 indexed publications, with 996 citations.

She is the founder and scientific coordinator of the research unit BioMark, Sensor Research (born in July 2011), which is a pole of the research group CINTESIS of the Faculty of Medicine of the Porto University since 2013. The research activities in BioMark target the development, modification and characterization of (bio)nanomaterials with specific functions and application in Medical and Industrial framework in multiple areas such as Bioengineering, Material Science, Electrical Engineering, Mechanical Engineering and Chemical Engineering. The technical areas involved include Nanoparticles, Nanochemistry, Nanomechanics and Nanotechnology of Biomaterials, with current application in different fields, including (1) Solar Cells and Fuel Cells; (2) Smart Nanomaterials, including Biomimetics applied in biomedicine and (bio)sensors, Selective sensory surfaces applied in (bio)sensors and Actuators sensitive to physical stimuli; (3) and New hybrid devices of sensory capacity. Current team members include 10 post-doctoral, 11 PhD and 1 master students.

From the several funded projects undergoing in BioMark, there are two major ones that are meant to create a new paradigm in biosensing technology. One is a Starting Grant, 3P’s, approved in 2012 by European Research Council, with a budget of 1 million euros (undergoing since February 2013) that she coordinates. This grant targets the development of fully autonomous devices to monitor cancer biomarkers, by merging separate fields of knowledge: Plastic Antibodies, Photovoltaics and Plasmonics. The other project is a FET-Open project, Symbiotic, approved for funding in 2015, with a budget over 3 million euros, by the European Commission, where the same target is to replace the photovoltaic by fuel cells.

 

Advertisements